Andrea Armstrong

Andrea Armstrong has extensive work experience in the biotechnology and pharmaceutical industries.

Andrea is currently serving as the Chief People Officer at Auron Therapeutics, a company focused on transforming cancer therapeutics through differentiation therapy.

Prior to that, they held the role of Interim Chief People Officer at EpiBiologics.

Andrea has also served as a Board Member of the Compensation Committee at Mana Therapeutics and NextRNA Therapeutics.

In addition, Andrea has held positions as the Chief People Officer at AI Proteins and Chroma Medicine, and as the Chief Administrative Officer at Celsius Therapeutics.

Andrea has also worked as a Strategic People Advisor at C4 Therapeutics and as the Interim Chief People Officer at Third Rock Ventures newco, which later became FAZE Medicines.

Andrea has a strong background in human resources and leadership roles within the biotech industry.

Andrea Armstrong has a BA in International Relations from Tufts University. Andrea also has an MA in Public Health from Boston University. The start and end years for both degrees are not provided.